Orphenadrine poisoning in a child: clinical and analytical data.

Intensive Care Med

Pediatric Intensive Care Unit, Academic Hospital of the Free University of Brussels, Laarbeeklaan 101, B-1090 Brussels Belgium.

Published: October 1999

Orphenadrine is an anticholinergic drug used mainly in the treatment of Parkinson's disease. It has a peripheral and central effect and a known cardiotoxic effect when taken in large doses. We report the successful outcome of the treatment of a 2 1/2-year-old girl who accidentally ingested 400 mg of orphenadrine hydrochloride (Disipal). One hour after ingestion she presented neurological symptoms: confusion, ataxic walking, and periods of severe agitation. Generalized tonic-clonic seizures appeared resistant to the administration of multiple antiepileptics. They ceased after a supplementary dose of intravenous diazepam, endotracheal intubation, and mechanical ventilation. An episode of ventricular tachycardia responded well to i. v. lidocaine. Physostigmine was administered in three successive doses. The initial orphenadrine plasma level (3,55 microg/ml) was in the toxic range, associated with high mortality. The calculated elimination half-life was 10.2 h and the molecule and/or its metabolites were found up to 90 h after ingestion.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s001340051024DOI Listing

Publication Analysis

Top Keywords

orphenadrine
4
orphenadrine poisoning
4
poisoning child
4
child clinical
4
clinical analytical
4
analytical data
4
data orphenadrine
4
orphenadrine anticholinergic
4
anticholinergic drug
4
drug treatment
4

Similar Publications

Seasonal monitoring, ecological risk assessment, and prioritization of pharmaceuticals in a tropical semi-enclosed bay (Santos, São Paulo coast, Brazil).

Mar Environ Res

December 2024

Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Avenida General Norton de Matos S/N, 4450-208, Matosinhos, Portugal; Escola das Ciências da Vida e do Ambiente (ECVA), Universidade de Trás-os-Montes e Alto Douro (UTAD), 5000-801, Vila Real, Portugal; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal.

Research on the occurrence and seasonal monitoring of pharmaceutically active compounds (PhACs) in estuarine and coastal waters has intensified recently. However, few studies have been conducted with PhACs flowing into the marine waters of South America (such as Brazil). Against this backdrop, the aims of this study were: (i) evaluate, for the first time, the seasonal occurrence throughout a year and the potential ecological risks of ten selected PhACs in marine bathing waters from Santos Bay, São Paulo, Brazil (a tropical low-wave energy semi-closed bay); and (ii) develop a list of high-priority PhACs for the monitoring based on "occurrence, persistence, bioaccumulation, and toxicity" criteria (OPBT).

View Article and Find Full Text PDF

Background: Muscle cramps are common in patients with cirrhosis. Despite their prevalence and impact on health-related quality of life, there are no widely used clinical practice guidelines for management of muscle cramps in cirrhosis. The aim of this review was to critically evaluate current evidence regarding treatment of muscle cramps in cirrhosis.

View Article and Find Full Text PDF
Article Synopsis
  • This study examined 384 post-operative cardiovascular disease (CVD) patients to evaluate the prevalence and impact of potential drug-drug interactions (pDDIs).
  • Using two drug interaction databases, Micromedex and Lexicomp, researchers found that nearly all patients had at least one pDDI, with a median of over 6 pDDIs per patient, and a significant percentage categorized as major interactions.
  • The research also identified unique interactions not documented in one of the databases, underscoring the importance of regular monitoring and the role of clinical pharmacists in preventing harmful pDDIs in high-risk patients.
View Article and Find Full Text PDF

Temporal variability and ecological risks of pharmaceuticals and cocaine during the Christmas and New Year holidays in a beach area of North Coast of São Paulo, Brazil.

Mar Environ Res

November 2024

Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Avenida General Norton de Matos S/N, 4450-208, Matosinhos, Portugal; Escola das Ciências da Vida e do Ambiente (ECVA), Universidade de Trás-os-Montes e Alto Douro (UTAD), 5000-801, Vila Real, Portugal; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal.

Article Synopsis
  • The study analyzed the presence and potential ecological risks of nine pharmaceuticals in the Juquehy River, which leads to a popular beach in São Paulo, Brazil.
  • Findings showed a significant increase in pharmaceutical concentrations during the busy holiday season compared to baseline levels, with caffeine and losartan being the most prevalent.
  • The ecological risk assessment indicated moderate environmental concerns for aquatic life, particularly from caffeine and losartan, highlighting risks to algae, crustaceans, and fish due to both acute and chronic exposure.
View Article and Find Full Text PDF

Objective: Evaluation of the analgesic, opioid-sparing, anti-inflammatory and adverse effects of the diclofenac and orphenadrine (Neodolpasse) fixed combination for analgesia in the postoperative period of surgical cancer patients.

Material And Methods: A randomized, single-center, prospective, comparative study evaluated two analgesic regimens in 40 cancer patients undergoing various open cavity surgeries, including extensive combined interventions associated with the resection of 3 or more organs. The study was conducted following the transfer from the ICU to the surgical department during the early activation period, within the first two postoperative days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!